CLOPIDOGREL BISULFATE (clopidogrel bisulfate) by Dr. Reddy's Laboratories is p2y 12 class of adp receptors on platelets. Approved for rate of myocardial infarction (mi), stroke in patients with non-st-segment elevation acs [unstable angina (ua)/non-st-elevation myocardial infarction (nstemi)], including patients and 5 more indications. First approved in 2008.
Drug data last refreshed 1w ago
P2Y 12 class of ADP receptors on platelets.
Worked on CLOPIDOGREL BISULFATE at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease Patients